Arcturus Therapeutics Holdings Inc.
ARCT
$6.72
$0.131.97%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -94.81% | 46.68% | 47.51% | -156.30% | 57.45% |
| Total Depreciation and Amortization | -16.34% | -14.30% | -11.39% | 0.49% | 10.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -39.15% | -35.51% | -34.10% | -0.05% | 5.39% |
| Change in Net Operating Assets | 62.27% | 84.43% | -379.45% | 1,287.50% | -4.80% |
| Cash from Operations | 27.83% | 80.91% | -532.32% | 54.85% | 26.67% |
| Capital Expenditure | -126.25% | 100.00% | 42.92% | 100.00% | 91.85% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -126.25% | 100.00% | 42.92% | 100.00% | 91.85% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 76.77% | -88.60% | -91.09% | -90.02% | -62.34% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 76.77% | -712.82% | 594.47% | 100.72% | -96.83% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 30.43% | 27.03% | -456.39% | 99.26% | -100.49% |